Literature DB >> 16794479

The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension.

María U Moreno1, Gorka San José, Ana Fortuño, Oscar Beloqui, Javier Díez, Guillermo Zalba.   

Abstract

OBJECTIVE: Oxidative stress is implicated in hypertension. The reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidases are the main source of superoxide in phagocytic and vascular cells. The C242T polymorphism of CYBA, the human gene that encodes p22phox, has been found to be functionally associated with vascular NADPH oxidase activity in atherosclerotic patients. We investigated the association of the C242T polymorphism with hypertension and its potential impact on NADPH oxidase activity. We also analysed the interaction of C242T polymorphism with the -930A/G CYBA variant.
DESIGN: Case-control study in a random sample of 623 subjects (326 hypertensive patients and 297 normotensive controls) from the general population.
METHODS: CYBA polymorphisms were determined by restriction fragment length polymorphism (RFLP) or allelic discrimination. NADPH oxidase activity and p22phox expression were quantified in phagocytic cells by chemiluminescence and by northern and western blots, respectively.
RESULTS: The prevalence of the CC genotype and the C allele frequency were significantly higher (P < 0.05) in hypertensives than in normotensives. CC genotype remained associated with hypertension after adjusting for potential confounders in a logistic regression analysis. Increased phagocytic NADPH oxidase activity was observed in CC hypertensives compared with CT and TT hypertensives (P < 0.05). Enhanced plasma levels of von Willebrand factor were found in CC hypertensives compared with TT hypertensives (P < 0.05). The C242T polymorphism was not in linkage disequilibrium with the -930A/G CYBA promoter variation, which also associates with hypertension.
CONCLUSION: The C242T CYBA polymorphism is associated with essential hypertension. Furthermore, hypertensives carrying the CC genotype of this polymorphism exhibit features of NADPH oxidase-mediated oxidative stress and endothelial damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794479     DOI: 10.1097/01.hjh.0000234110.54110.56

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  21 in total

1.  Resurrecting hope for antioxidant treatment of cardiovascular disease: focus on mitochondria.

Authors:  Paul M O'Connor; David D Gutterman
Journal:  Circ Res       Date:  2010-07-09       Impact factor: 17.367

2.  CYBA (p22phox) variants associate with blood pressure and oxidative stress markers in hypertension: a replication study in populations of diverse altitudes.

Authors:  Rahul Kumar; Samantha Kohli; Zahara Ali; Kanika Duhan; Rekhbala Ram; Mohit Gupta; Sanjay Tyagi; Ghulam Mohammad; Ma Qadar Pasha
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

Review 3.  Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease.

Authors:  Pravin Kesarwani; Anuradha K Murali; Amir A Al-Khami; Shikhar Mehrotra
Journal:  Antioxid Redox Signal       Date:  2012-10-15       Impact factor: 8.401

4.  Exercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension.

Authors:  Deborah L Feairheller; Michael D Brown; Joon-Young Park; Tina E Brinkley; Samar Basu; James M Hagberg; Robert E Ferrell; Nicola M Fenty-Stewart
Journal:  Med Sci Sports Exerc       Date:  2009-07       Impact factor: 5.411

Review 5.  NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology.

Authors:  Randall S Frey; Masuko Ushio-Fukai; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

6.  G allele of the -930A>G polymorphism of the CYBA gene is associated with insulin resistance in obese subjects.

Authors:  M C Ochoa; C Razquin; G Zalba; M A Martínez-González; J A Martínez; A Marti
Journal:  J Physiol Biochem       Date:  2008-06       Impact factor: 4.158

Review 7.  Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.

Authors:  Augusto C Montezano; Rhian M Touyz
Journal:  Antioxid Redox Signal       Date:  2013-06-06       Impact factor: 8.401

8.  Association of NADPH oxidase p22phox gene C242T, A640G and -930A/G polymorphisms with primary knee osteoarthritis in the Greek population.

Authors:  Panagiotis Lepetsos; Andreas Pampanos; Stergios Lallos; Emmanouil Kanavakis; Dimitrios Korres; Athanasios G Papavassiliou; Nicolaos Efstathopoulos
Journal:  Mol Biol Rep       Date:  2013-08-07       Impact factor: 2.316

9.  Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy.

Authors:  Joanna Sladowska-Kozłowska; Mieczysław Litwin; Anna Niemirska; Paweł Płudowski; Aldona Wierzbicka; Ewa Skorupa; Zbigniew T Wawer; Roman Janas
Journal:  Pediatr Nephrol       Date:  2012-06-02       Impact factor: 3.714

10.  Extensive natural variation for cellular hydrogen peroxide release is genetically controlled.

Authors:  Homa Attar; Karen Bedard; Eugenia Migliavacca; Maryline Gagnebin; Yann Dupré; Patrick Descombes; Christelle Borel; Samuel Deutsch; Holger Prokisch; Thomas Meitinger; Divya Mehta; Erich Wichmann; Jean Maurice Delabar; Emmanouil T Dermitzakis; Karl-Heinz Krause; Stylianos E Antonarakis
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.